Cell Biology Program

The Xuejun Jiang Lab

Research

PI - Xuejun Jiang
Xuejun Jiang, PhD
Virginia and Daniel K. Ludwig Chair 1

The research of my laboratory focuses on two directions highly relevant to cancer biology, (1) the molecular basis of programmed cell death processes (including apoptosis and ferroptosis), and their roles in human disease; and (2) the molecular basis of autophagy and its role in cancer. We also study various cancer signaling and cellular metabolic events, especially those involved in cell death/survival determination. We aim to translate our basic research finding into potential therapeutic approaches. To achieve these goals, the laboratory utilizes a combination of approaches including biochemistry, chemical biology, proteomics, molecular cell biology, high-throughput screening, 3-dimensional microfluidic cell array, and mouse modeling.

View Lab Overview

Xuejun Jiang Lab Group Photo 2023

Publications Highlights

People

PI - Xuejun Jiang

Xuejun Jiang, PhD

Virginia and Daniel K. Ludwig Chair 1

  • Cell biologist Xuejun Jiang studies programmed cell death, molecular mechanisms, and their roles in tumorigenesis.
  • PhD, University of Texas Southwestern Medical Center at Dallas
[email protected]
Email Address
212-639-6814
Office Phone

Members

Nicholas Carbone
Nicholas Carbone

Graduate Student, Tri-I PhD Program in Chemical Biology

Peter Chhoy

Graduate Student, GSK

Maria Chui
Maria Chui

Administrative Assistant, Sr.

Jiachen Hu
Jiachen Hu

Graduate Student, GSK

Yingying Hu

Graduate Student, Tri-I PhD Program in Chemical Biology

Xuejun Jiang, PhD
Xuejun Jiang

Lab Head

Jinnie Kim

Graduate Student, WCMC

Pei Liu
Pei Liu

Research Fellow

Xuesong Liu
Xuesong Liu

Research Scholar

Atara Neugroschl
Atara R Neugroschl

Graduate Student, Tri-I PhD Program in Chemical Biology

Nanfang Peng
Nanfang Peng

Senior Research Scientist

Lab Alumni
Fahad Benthani
Fahad Benthani

University Assistant at Johannes Kepler University

Guoqing Chen, PhD
Guoqing Chen
Taya Feldman

Scientist, International Flavors & Fragrances

Yan Feng, PhD
Yan Feng

Principal Scientist, Accutar Therapeutics

Noor Gammoh, PhD
Noor Gammoh

Group Leader - Reader, The University of Edinburgh

Ian G Ganley

Programme Leader at MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee

Minghui Gao
Minghui Gao

Principal Investigator and Professor, Harbin Institute of Technology

Zhonghua Gao

Associate Professor, Department of Biochemistry and Molecular Biology, Penn State Cancer Institute

Guochang Huang

Research Scientist, MSKCC

Fnu Sankar Jagadeeshan

Postdoc Research Fellow at Ben Gurion University of the Negev, Israel

Helen Kang

Manager of Regulatory Affairs Strategy, Regeneron Pharmaceuticals, Inc.

Deguang Liang, PhD
Deguang Liang

Assistant Investigator, Chinese Institutes for Medical Research Beijing

Alexander Minikes
Alexander Minikes

Scientist, Lime Therapeutics

Prashant Monian
Prashant Monian

Principal Scientist at Wave Life Sciences, Boston, MA

Cindy Puente
Cindy Puente

Freelance, Medical Communications Consultant

Yufang Shao

President and Founder of Bon Opus Biosciences

Yuji Shi
Yuji Shi

R&D Director, HydroGene Therapeutics

Yu Song

Vice Director at Zhangjiagang Hospital

Shivangi Srivastava

Drug Discovery Scientist, Bristol Myers Squibb

Hua Wang
Hua Wang

Principal Investigator, Peking University International Cancer Center

Junru Wang, PhD
Junru Wang
Xinjiang Wang

Principal Investigator at Roswell Park Cancer Institute

Megan Wong

Graduate Student, SUNY Downstate Health Sciences University

Pui-Mun Wong
Pui-Mun Wong

Innovative Cell biology Researcher at National Singapore University

Jiao Wu, PhD
Jiao Wu

Professor at Fourth Military Medical University, Xi'an

Junmei Yi
Junmei Yi
Tao Yun

Program Manager at Center Ministry of Science and Technology, China

Rui Zhang

Professor at Air Force Military Medical University, China

Zechuan Zhao

Graduate Student, WCMC

Hong Zhou

Exchange Graduate Student

Lab Affiliations

Achievements

  • Louis and Allston Boyer Young Investigator Award for Basic Research, Memorial Sloan Kettering Cancer Center (2007)
  • Scholar, American Cancer Society (2007-2010)
  • Catherine and Frederick Adler Chair for junior faculty, Memorial Sloan Kettering Cancer Center (2006)
  • V Scholar, The V Foundation for Cancer Research (2004-2006 )
  • Alfred Bressler Scholar, Alref W. Bresller Scholars Fund (2004-2007)
Read more
  • Sigma Xi Award, UT Southwestern (1998)
  • Robert A. Welch Predoctoral Fellowship, UT Southwestern (1995-1999)

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Career Opportunities

 

Apply now

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Xuejun Jiang discloses the following relationships and financial interests:

  • Exarta Therapeutics
    Equity; Fiduciary Role / Position; Intellectual Property Rights; Professional Services and Activities
  • Lime Therapeutics, Inc.
    Equity; Professional Services and Activities (Uncompensated)
  • VivoZ Biolabs, LLC
    Intellectual Property Rights; Professional Services and Activities (Uncompensated)

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures